| Michelle A Adu-darko, MD | |
|
1215 Lee St, Charlottesville, VA 22908-4319 | |
| (434) 924-1761 | |
| (434) 982-3561 |
| Full Name | Michelle A Adu-darko |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467642298 | NPI | - | NPPES |
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
BG Medicine, Inc. announced today that it has entered into an agreement with Inverness Medical Innovations, Inc.—a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management—for the development and commercialization of a galectin-3 test for Inverness' Triage® Meter Pro®. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure.
Australian Medical Association (AMA) President, Dr Bill Glasson, said recently that reports of Government changes to the health system seemed to have the priorities all wrong.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.
Diabetes continues to be the leading cause of new cases of blindness among adults in the United States. But the current shortage of eye-care providers would make it impossible to keep up with demand to provide the requisite annual screenings for this population.
Researchers at the University of California, San Diego, the Medical University of South Carolina and American Life Science Pharmaceuticals of San Diego have demonstrated that oral administration of a cysteine protease inhibitor, E64d, not only reduces the build-up of β-amyloid in the brains of animal models for Alzheimer's disease, but also results in a substantial improvement in memory deficit.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle A Adu-darko, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Michelle A Adu-darko, MD 1215 Lee St, Charlottesville, VA 22908-4319 Ph: (434) 924-1761 |
News Archive
BG Medicine, Inc. announced today that it has entered into an agreement with Inverness Medical Innovations, Inc.—a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management—for the development and commercialization of a galectin-3 test for Inverness' Triage® Meter Pro®. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure.
Australian Medical Association (AMA) President, Dr Bill Glasson, said recently that reports of Government changes to the health system seemed to have the priorities all wrong.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.
Diabetes continues to be the leading cause of new cases of blindness among adults in the United States. But the current shortage of eye-care providers would make it impossible to keep up with demand to provide the requisite annual screenings for this population.
Researchers at the University of California, San Diego, the Medical University of South Carolina and American Life Science Pharmaceuticals of San Diego have demonstrated that oral administration of a cysteine protease inhibitor, E64d, not only reduces the build-up of β-amyloid in the brains of animal models for Alzheimer's disease, but also results in a substantial improvement in memory deficit.
› Verified 5 days ago
Mr. Michael Douglas Dickens, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1011 E Jefferson St, Charlottesville, VA 22902 Phone: 434-296-9161 Fax: 434-296-1036 | |
Linda A. Waggoner Fountain, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-0123 Fax: 434-243-3300 | |
Marion Elizabeth Szwedo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1011 E Jefferson St, Charlottesville, VA 22902 Phone: 434-296-9161 Fax: 434-977-6068 | |
Dr. Gregory Rees Sturz, DO, PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Box 800501, Charlottesville, VA 22908 Phone: 494-942-5321 Fax: 434-982-3816 | |
Anne C Butz, LCSW Pediatrics Medicare: Medicare Enrolled Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-5321 Fax: 434-244-4412 | |
Jessica C Di Zio, PNP Pediatrics Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-1761 Fax: 434-982-3561 | |
Brooke D. Vergales, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2335 Fax: 434-982-0796 |